| Literature DB >> 26930490 |
Richard Nolz1, Asenbaum Ulrika2, Julia Furtner3, Ramona Woitek2, Sylvia Unterhumer1, Andreas Wibmer1, Alexander Prusa4, Christian Loewe1, Maria Schoder1.
Abstract
PURPOSE: To define the diagnostic precision of non-specialized readers in the detection of type 2 endoleaks (T2EL) in arterial versus venous phase acquisitions, and to evaluate an approach for radiation dose reduction.Entities:
Mesh:
Year: 2016 PMID: 26930490 PMCID: PMC4773111 DOI: 10.1371/journal.pone.0149725
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Acquisition parameters.
| 16-slice scanner | Dual-source scanner | |
|---|---|---|
| 120 | Ref 120 (Care kV) | |
| 120 | 120 | |
| 16 x 0.75 | 2 x 64 x 0.6 | |
| 0.5 | 0.28 | |
| ≈ 1 | ≈ 1 | |
| B30 | B30 |
kV = kilovolt, refmAs = reference milliampereseconds, mm = millimeter, sec = seconds.
Type 2 endoleak detection.
| n = 334 | Sensitivity | Specificity | PPV | NPV | Accuracy | p | |
|---|---|---|---|---|---|---|---|
| 80.9 (95% CI: 72.9–87.1) | 93.1 (95% CI: 88.5–96.0) | 88.3 (95% CI: 80.9–93.2) | 88.3 (95% CI: 83.1–92.2) | 88.3 (95% CI: 84.3–91.5) | 0.092 | ||
| 85.5 (95% CI: 78.0–90.8) | 92.6 (95% CI: 87.9–95.7) | 88.2 (95% CI: 81.0–93.0) | 90.8 (95% CI: 85.8–94.2) | 89.8 (95% CI: 85.9–92.8) | |||
| 73.3 (95% CI: 64.7–80.5) | 93.6 (95% CI: 89.1–96.4) | 88.1 (95% CI: 80.1–93.2) | 84.4 (95% CI: 78.9–88.8) | 85.6 (95% CI: 81.3–89.1) | 0.152 | ||
| 79.4 (95% CI: 71.3–85.8) | 93.6 (95% CI: 89.1–96.4) | 88.9 (95% CI: 81.4–93.7) | 87.6 (95% CI: 82.2–91.5) | 88.0 (95% CI: 83.9–91.2) | |||
PPV = positive predictive value, NPV = negative predictive value, p = sensitivity arterial set versus sensitivity venous set; statistical data in S1 Data.
Fig 1Feeding vessel detection in arterial and venous phase acquisition.
(a) Arterial phase acquisition: Clearly perceptible blush of contrast agent in the aneurysm sac (arrow) indicative of the presence of a type 2 endoleak. Consecutive, feeding lumbar arteries of this segment show the same contrast as the aorta (arrowheads). (b) Venous phase acquisition: Similarly, clearly detectable type 2 endoleak (arrow). However, potentially feeding lumbar arteries show no contrast enhancement (arrowheads).
Sac diameters.
| Total (n = 167) | Type 2 endoleaks meeting criteria for re-intervention (n = 20) | |||||
|---|---|---|---|---|---|---|
| Pre-discharge MSCTA | Last follow-up MSCTA | Sac diameter change | Pre-discharge MSCTA | Last follow-up MSCTA | Sac diameter change | |
| 60.1 ± 9.2mm | 56.3 ± 13.5mm | - 3.0 (IQR: -10.0–1.0) mm | 59.9 ± 7.0mm | 71.9 ± 9.0mm | 8.5 (IQR: - 7.3–13.8) mm | |
| 60.0 ± 9.5mm | 56.1 ± 13.8mm | - 3.0 (IQR: -9.0–1.0) mm | 60.4 ± 7.3mm | 71.4 ± 9.8mm | 7.5 (IQR: - 6.0–14.5) mm | |
| 60.1 ± 9.2 mm | 56.3 ± 13.4mm | - 3.0 (IQR: -9.0–2.0) mm | 60.1 ± 7.0mm | 71.4 ± 9.0mm | 8.0 (IQR: 6.0–13.0) mm | |
MSCTA = multi-slice computer tomography angiography, mm = millimeter, IQR = interquartile range; statistical data in S1 Data.
Fig 2Scatterplots of diameter measurements of the aneurysm sac.
Comparison of diameter measurements of the aneurysm sac (n = 334) between (a) gold standard and reader 1, (b) gold standard and reader 2, and (c) reader 1 and reader 2. The solid line denotes the mean of the differences (md) between compared groups. Dashed lines indicate the upper and lower limits of the agreement region (md ± [1.96 x SD]), where SD is the standard deviation of differences. mm = millimeter.
Dose calculations.
| n = 289 | Effective dose (mSv) | % | DLP (mGy*cm) |
|---|---|---|---|
| 14.6 ± 6.7 (95% CI: 13.8–15.4) | 100 | 858.7 ± 395.3 (95% CI: 809.1–908.2) | |
| 0.4 ± 0.3 (95% CI: 0.3–0.4) | 2.4 | 20.3 ± 16.5 (95% CI: 18.3–22.4) | |
| 8.6 ± 4.4 (95% CI: 8.0–9.1) | 58.6 | 503.8 ± 257.4 (95% CI: 471.5–536.0) | |
| 5.7 ± 3.1 (95% CI: 5.3–6.1) | 39.0 | 334.6 ± 183.9 (95% CI: 311.5–357.6) |
mSv = millisievert, DLP = dose length product, mGy*cm = milligray*centimeter, CI = confidence interval; statistical data in S1 Data.